Xtrava Inc.

MicroLab Platform is an accurate low cost digital rapid testing solution for COVID-19.

Xtrava Inc. is active in the health space based in Tokyo, Japan.

Profile

Xtrava Inc. is a health company offering the MicroLab Platform, an accurate and cost-effective digital rapid testing solution for COVID-19. The MicroLab Platform provides a reliable method for quick and efficient testing, aiding in the timely identification and management of COVID-19 cases. With a focus on advancing healthcare technology, Xtrava Inc. aims to contribute to public health efforts by providing accessible and accurate testing solutions. The company's commitment to innovation and quality in the healthcare sector underscores its dedication to improving diagnostic capabilities and supporting global health initiatives.

The company sits in the health segment, where it competes on its core product or service.

The company is recorded as being based in Tokyo, Japan.

Its current recorded stage is Plug and Play accelerated startup.

Website: www.xtrava.ai